Physician

Iman Mohamed, M.D.

According to 2025 Medicare claims, Iman Mohamed, M.D. (NPI: 1942297270) practices hematology/oncology in the Kalamazoo-Portage, MI market, with the plurality of this provider's patient population coming from Kalamazoo, MI. This provider's primary affiliated billing organization is ASCENSION MEDICAL GROUP PROMED (NPI: 1720009954; TIN: 383193801) and primary practice location at 49009-1904.

Mohamed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 307 traditional Medicare patients, billed 66,092 HCPCS/CPT codes, and received $901,780 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 562 prescription claims across 171 beneficiaries totaling $1,072,985 in drug costs, led by Ibrance (Palbociclib). 2021 DME data shows 31 claims. Open Payments data shows 4 records totaling $117. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $100,670 to $901,780. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $462,253 and ending at $1,072,985. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	233	1,490	$100,670
2016	270	2,239	$153,759
2017	125	385	$45,012
2018	203	4,042	$111,008
2019	303	31,304	$627,089
2020	281	50,281	$820,986
2021	311	59,631	$542,856
2022	295	31,346	$578,271
2023	268	51,727	$715,922
2024	307	66,092	$901,780

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	229	1,244	$462,253
2016	198	973	$602,065
2017	135	585	$271,185
2018	149	263	$21,560
2019	253	960	$234,628
2020	246	980	$186,972
2021	309	1,126	$469,401
2022	254	810	$567,002
2023	206	756	$1,026,298
2024	171	562	$1,072,985

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	80	$35,408
2016	15	63	$27,397
2017	N/R	24	$11,263
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	32	$2,913
2021	N/R	31	$3,274
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	50	126	$86
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	47	74	$64
80053	Blood test, comprehensive group of blood chemicals	172	345	$10
96372	Injection of drug or substance under skin or into muscle	62	139	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	191	398	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	35	980	$566,612
Anastrozole	Anastrozole	161	14,254	$5,867
Letrozole	Letrozole	75	6,231	$4,837
Dexamethasone	Dexamethasone	45	660	$737
Ondansetron Hcl	Ondansetron Hcl	38	625	$411

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$117	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Iman Mohamed, M.D.?

Tedicare shows public-source Medicare data for Iman Mohamed, M.D. (NPI 1942297270), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Iman Mohamed, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Iman Mohamed, M.D.?

Iman Mohamed, M.D. is linked to ASCENSION MEDICAL GROUP PROMED (billing NPI 1720009954) in the available physician profile data.

Does Iman Mohamed, M.D. have Open Payments data?

Iman Mohamed, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.